New tool may spare women unnecessary organ removal during bladder cancer surgery
NCT ID NCT06184516
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a decision tool to help select women with bladder cancer who can safely keep their reproductive organs during bladder removal surgery. Currently, standard surgery removes the bladder, uterus, ovaries, and part of the vagina, which can harm sexual health, mental health, and increase heart and bone risks. The tool uses MRI and cystoscopy to identify low-risk patients, aiming to preserve quality of life without compromising cancer control. About 127 women will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA BLADDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32608, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bladder-Instilled biologic keep recurrent bladder cancer at bay?
- New combo aims to wipe out rare bladder cancer before surgery
- Bladder cancer patients may avoid surgery with new drug
- New combo therapy for bladder cancer passes first safety test?
- Experimental combo aims to supercharge cancer immunotherapy
- Step up to surgery: daily walks may cut bladder cancer operation risks